Clin Res Cardiol (2023). https://doi.org/10.1007/s00392-023-02180-w

Right Ventricular Cardiac Power Index Predicts 1 Year Outcome after Transcatheter Edge-to-Edge-Repair for Severe Tricuspid Valve Regurgitation
U. Hanses1, K. Diehl1, A. Ben Ammar1, P. Dierks1, A. Fach1, C. Frerker2, I. Eitel2, H. Wienbergen3, R. Hambrecht1, R. Osteresch1
1Klinik für Kardiologie und Angiologie, Klinikum Links der Weser, Bremen; 2Medizinische Klinik II / Kardiologie, Angiologie, Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Lübeck; 3Bremer Institut für Herz- und Kreislaufforschung (BIHKF), Bremen;

Background: Transcatheter edge-to-edge repair (TEER) for severe tricuspid regurgitation (TR) emerged as a novel treatment option for patients (pts.) not amenable for surgery. However, knowledge regarding independent risk factors for worse prognosis is rarely available.

Objective: The study sought to investigate the impact of right ventricular cardiac power index (RVCPi) on 1-year outcome in pts. with severe symptomatic TR undergoing TEER.

Methods: Consecutive pts. with severe TR who underwent TEER between 08/2020 to 11/2021 were included and followed prospectively. Baseline clinical and invasive hemodynamic variables, changes in echocardiographic parameters and New York Heart Association (NYHA) functional class, periprocedural and in-hospital major adverse events were assessed. Primary endpoint was defined as a composite of all-cause mortality and heart failure hospitalization at 1-year after TEER. A multivariable Cox proportional-hazards regression analysis was performed to identify independent risk factors for combined primary endpoint. RVCPi was calculated as: [Cardiac index * mean pulmonary pressure] * K (conversion factor 2.22 × 10-3) = W/m². Receiver operator characteristic (ROC) analysis was used to determine discriminative capacity of RVCPi. The prognostic value of RVCPi threshold was tested using Kaplan-Meier analysis.

Results: 90 patients (median age 81±5.8 years, 51.1% women) at high operative risk (LogEuro-Score 18.4±13.1%) underwent TEER for severe TR. Primary endpoint occurred in 30 patients (33.3%). ROC curve analysis demonstrated that RVCPi was associated with an area under the curve of 0.70 (95% confidence interval (CI) 0.57-0.84; p=0.008). RVCPi threshold of 0.15 W/m² (simple nearest-to-median value) was associated with 64.3% sensitivity and 64.5% specificity for the combined primary endpoint. Event-free survival was significantly higher in the RVCPi < 0.15 W/m² group compared to those with RVCPi ≥ 0.15 W/m² (20.9% vs. 45.0%; log-rank p=0.04). In Cox regression analysis RVCPi was an independent predictor for the combined primary endpoint (Hazard ratio 6.9; 95% CI 1.4-33.9; p=0.017).

Conclusions: RVCPi is associated with outcome among pts. undergoing TEER for severe TR. 

Therefore, this hemodynamic predictor might be useful in risk stratification of TEER candidates with severe TR.


https://dgk.org/kongress_programme/jt2023/aV1654.html